Neumora Therapeutics, Inc. Common StockNMRANASDAQ
Loading
Net Income ContractionContracting
Percentile Rank40
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-236.30M
↓ 20% vs avg
Percentile
P40
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-197.25M
Historical baseline
PeriodValueYoY Change
TTM$-236.30M+3.1%
2024$-243.79M-3.3%
2023$-235.93M-80.2%
2022$-130.90M+44.8%
2021$-237.31M-139.1%
2020$-99.27M-